Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
497.35
-7.60 (-1.51%)
At close: Jan 21, 2026, 4:00 PM EST
496.97
-0.38 (-0.08%)
After-hours: Jan 21, 2026, 4:15 PM EST
Madrigal Pharmaceuticals Employees
Madrigal Pharmaceuticals had 528 employees as of December 31, 2024. The number of employees increased by 152 or 40.43% compared to the previous year.
Employees
528
Change (1Y)
152
Growth (1Y)
40.43%
Revenue / Employee
$1,402,727
Profits / Employee
-$547,585
Market Cap
11.30B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 528 | 152 | 40.43% |
| Dec 31, 2023 | 376 | 284 | 308.70% |
| Dec 31, 2022 | 92 | 21 | 29.58% |
| Dec 31, 2021 | 71 | 29 | 69.05% |
| Dec 31, 2020 | 42 | 13 | 44.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bio-Techne | 3,100 |
| BioMarin Pharmaceutical | 3,040 |
| Jazz Pharmaceuticals | 2,800 |
| Exelixis | 1,147 |
| Ionis Pharmaceuticals | 1,069 |
| Ascendis Pharma | 1,017 |
| Axsome Therapeutics | 683 |
| Avidity Biosciences | 391 |
MDGL News
- 8 days ago - Madrigal Pharmaceuticals, Inc. (MDGL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 12 days ago - Madrigal Expands its MASH Pipeline with Exclusive Global License Agreement for Ervogastat, a Phase 2 Oral DGAT-2 Inhibitor - GlobeNewsWire
- 16 days ago - Madrigal: Rezdiffra Shift To F4c MASH Cirrhosis Continues With 2-Year Data - Seeking Alpha
- 4 weeks ago - Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Madrigal Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Madrigal Pharmaceuticals, Inc. (MDGL) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Madrigal Presents New Data Demonstrating Rezdiffra® (resmetirom) Significantly Improved Multiple Noninvasive Imaging Tests and Biomarkers in Patients with Compensated MASH Cirrhosis - GlobeNewsWire